PharmEasy is one of India's largest digital healthcare platforms, offering medicine delivery, diagnostic tests, and teleconsultation services. The company has revolutionized healthcare accessibility with its robust e-commerce platform.
| Company Name | PharmEasy – API Holdings Limited |
|---|---|
| Promoter | Dr. Dhaval Shah |
| Est. Year | 2015 |
| Industry | Healthcare and E-commerce |
| ISIN No | INE0DJ201029 |
| Face Value | ₹1 |
| Website Link | Visit Our Website ↗ |
PharmEasy has shown strong revenue growth, driven by an increasing customer base and strategic acquisitions like Thyrocare. However, the company is still in its investment phase, focusing on scaling operations.
PharmEasy Pre-IPO shares offer investors an opportunity to participate in the rapidly growing online healthcare market in India.
Rising demand for online healthcare, expansion into diagnostics and insurance, and increasing digital adoption.
PharmEasy is integrating AI-driven health monitoring tools and expanding its supply chain infrastructure for faster deliveries.
